Why Eli Lilly Stock is the ‘Nvidia’ of GLP-1 Meds by Mark Eisenberg 23.09.2024 Investing in Eli Lilly now could mimic early Nvidia gains in AI. Learn why GLP-1 drugs are transforming healthcare investing.